ArticleIn vivo (Athens, Greece)
Course of Step Counts During Systemic Treatment for Non-small Cell Lung Cancer-Observational Data from a Prematurely Terminated Prospective Study.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimPatients receiving systemic treatment for non-small cell lung cancer (NSCLC) may experience significant fatigue leading to decrease in physical activity. An app reminding them to reach a pre-defined daily step count may be useful. The APACHIE-01 trial aimed to investigate step counts during systemic treatment and form the basis of a complimentary prospective trial testing a reminder app. PATIENTS AND
methodsPrimary endpoint was the mean step count per week during the first three cycles of systemic treatment (weeks three, six, and nine) in relation to the pre-treatment step count (baseline). Recruitment of the required 38 patients with advanced NSCLC should be completed within four months. Since only three patients were included during this period, the trial was stopped prematurely. Given the very small sample size, analyses were descriptive and exploratory in nature.
resultsMean weekly step counts at baseline were 2,451, 7,250, and 4,877 steps (mean value=4,859±2,400 steps; timepoint A). Mean values during weeks three (timepoint B), six (timepoint C), and nine (timepoint D) were 3,114±2,568, 2,837±750, and 1,224±44 (only two patients available) steps, respectively. Comparisons of mean step counts revealed numerical decreases, particularly between timepoints A and D.
conclusionIt was unexpectedly difficult to recruit patients for the APACHIE-01 trial. Given the very low number of participants, the results of the APACHIE-01 trial can only serve for descriptive orientation. The decrease of the mean step count may justify further exploratory investigations during systemic treatment and support the idea of an app reminding NSCLC patients to walk a pre-defined number of steps per day.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.